What’s driving the rapid growth of the top 20 biopharma companies in the world?
I’ve been remarking for some time now that the whole biopharma sector globally has grown enormously over the past few years. And thanks to the investment bankers at Torreya I can add a few numbers to put that into perspective, along with the booming role that China has played and is likely to continue to play over the next generation.
One of the charts that really leaped out at me was a look at the market valuations of the top 20 companies. In the past 6 years, says Torreya’s new report out on the industry, those valuations have doubled in size, growing from about $1.45 trillion to very close to $3 trillion.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
